Timothy R. Franson serves as Executive at Cidara Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Timothy R. Franson has executed 11 insider transactions totaling $92.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 21, 2023 involved selling 20,000 shares valued at $0.
Timothy R. Franson currently holds 20,000 shares of Cidara Therapeutics, Inc. (CDTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Timothy R. Franson has been a net buyer of CDTX stock. They have purchased $78.8K and sold $13.2K worth of shares.
Timothy R. Franson's most recent insider trade was on Sep 21, 2023, when they sold 20,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 21, 2023 | PRTK | $13.2K | Sale | 7,000 | $1.88 | Discretionary |
| Feb 8, 2023 | PRTK | $0 | Award | 20,000 | $N/A | Discretionary |
| Feb 16, 2022 | PRTK | $0 | Award | 20,000 | $N/A | Discretionary |
| Sep 13, 2021 | CDTX | $14.8K | Purchase | 7,000 | $2.12 | Discretionary |
| Feb 18, 2021 | PRTK | $0 | Award | 9,000 | $N/A | Discretionary |
| Feb 19, 2020 | PRTK | $0 | Award | 9,000 | $N/A | Discretionary |
| Feb 26, 2019 | PRTK | $0 | Award | 7,500 | $N/A | Discretionary |
| Feb 14, 2018 | PRTK | $0 | Award | 7,500 | $N/A | Discretionary |
| Apr 20, 2015 | CDTX | $64.0K | Purchase | 4,000 | $16.00 | Discretionary |